RadNet (RDNT) to Release Earnings on Friday

RadNet (NASDAQ:RDNT) is projected to release its earnings data before the market opens on Friday, February 28th. Analysts expect RadNet to post earnings of $0.21 per share and revenue of $459.42 million for the quarter. Persons that are interested in registering for the company’s earnings conference call can do so using this link.

RadNet Trading Down 0.8 %

Shares of RadNet stock opened at $59.67 on Wednesday. The company has a current ratio of 2.16, a quick ratio of 2.16 and a debt-to-equity ratio of 0.89. RadNet has a 12-month low of $36.47 and a 12-month high of $93.65. The firm has a market capitalization of $4.42 billion, a price-to-earnings ratio of -852.31 and a beta of 1.79. The firm’s 50 day simple moving average is $66.64 and its two-hundred day simple moving average is $69.22.

Analysts Set New Price Targets

A number of brokerages have issued reports on RDNT. Truist Financial restated a “buy” rating and set a $88.00 price target (down previously from $94.00) on shares of RadNet in a research note on Wednesday, January 22nd. Jefferies Financial Group cut their price target on shares of RadNet from $100.00 to $80.00 and set a “buy” rating on the stock in a research note on Wednesday, January 15th. Finally, Barclays cut their price objective on shares of RadNet from $85.00 to $74.00 and set an “overweight” rating on the stock in a research note on Wednesday, January 22nd. One equities research analyst has rated the stock with a sell rating, four have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $75.50.

RadNet Company Profile

RadNet, Inc, together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services.